CorMedix Inc (NASDAQ: CRMD) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

CorMedix Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of CorMedix Inc is $323.83M. A total of 0.75 million shares were traded on the day, compared to an average of 606.08K shares.

In the most recent transaction, Todisco Joseph bought 13,561 shares of CRMD for 3.74 per share on Mar 13 ’24. After the transaction, the Chief Executive Officer now owns 352,839 company shares. In a previous transaction on Dec 15 ’23, DUNTON ALAN W bought 3,000 shares at 3.30 per share. CRMD shares that Director owns now total 15,250.

Among the insiders who bought shares, DUNTON ALAN W acquired of 3,000 shares on Dec 14 ’23 at a per-share price of $3.45. This resulted in the Director holding 12,250 shares of CRMD after the transaction. In another insider transaction, Mistry Erin bought 1,000 shares at $4.00 per share on Nov 17 ’23. Company shares held by the Chief Commercial Officer now total 4,900.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CRMD has a high of $7.00 and a low of $2.57.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CRMD’s latest balance sheet shows that the firm has $65.47M in Cash & Short Term Investments as of fiscal 2021. There were $923.80k in debt and $5.35M in liabilities at the time. Its Book Value Per Share was $1.28, while its Total Shareholder’s Equity was $62.80M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRMD is Buy with a score of 4.50.

Most Popular

Related Posts